Blinded Comparison of Cefuroxime to Cefaclor for Lower Respiratory Tract Infections

Archives of Internal Medicine

Volumn 148, Issue 2, 1988, Pages 343-348

  Schleupner, Charles J ^a,b   Anthony, William C ^c   Tan, James ^d,e   File, Thomas M ^d   Lifland, Patti ^b   Craig, William ^f   Vogelman, Bennett ^f  

^a UNIVERSITY OF VIRGINIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Maryland General Hospital   (United States)

^d Department of Medicine Akron ^*  (United States)

^e NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFACLOR; CEFUROXIME;

ADULT; BRONCHITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PNEUMONIA; RESPIRATORY TRACT INFECTION;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; AGED; BACTERIAL INFECTIONS; BRONCHITIS; CEFACLOR; CEFUROXIME; CEPHALEXIN; CEPHALOSPORINS; CLINICAL TRIALS; COMPARATIVE STUDY; DRUG THERAPY; FEMALE; HUMAN; MALE; MIDDLE AGE; PNEUMONIA; PRODRUGS; RANDOM ALLOCATION; RESPIRATORY TRACT INFECTIONS; SUPPORT, NON-U.S. GOV'T;

EID: 0023857341     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1988.00380020087014     Document Type: Article

References (27)

1. 1. McKellar PP: Treatment of community acquired pneumonias. Am J Med 1985;79(suppl 2A):25-31.
2. 2. Slevin NJ, Aitken J, Thornley PE: Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections. Lancet 1984;1: 782-783.
3. 3. Stratton CW, Hawley HB, Horsman TA, et al: Hemophilus influenza pneumonia in adults. Am Rev Respir Dis 1980;121:595-598.
4. 4. Sweeney KG, Verghese A, Needham CA: In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains. Antimicrob Agents Chemother 1985;27: 499-502.
5. 5. Cockerill FR III, Edson RS: Trimethoprim-sulfamethoxazole. Mayo Clin Proc 1983;58:147-153.
6. 6. Thompson RL, Wright AJ: Cephalosporin antibiotics. Mayo Clin Proc 1983;58:79-87.
7. 7. Washington JA II, Wilson WR: Erythromycin: I. A microbial and clinical perspective after 30 years of clinical use. Mayo Clin Proc 1985;60: 189-203.
8. 8. Washington JA II, Wilson WR: Erythromycin: II. A microbial and clinical perspective after 30 years of clinical use. Mayo Clin Proc 1985;60: 271-278.
9. 9. Nelson JD: Cefuroxime: A cephalosporin with unique applicability to pediatric practice. Pediatr Infect Dis 1983;2:394-396.
10. 10. Jones RN, Fuchs PC, Gavan TL, et al: Cefuroxime, a new parenteral cephalosporin: Collaborative in vitro susceptibility comparison with cephalothin against 5887 clinical bacterial isolates. Antimicrob Agents Chemother 1977;12:47-50.
11. 11. Neu HC, Fu KP: Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity. Antimicrob Agents Chemother 1978;13:657-664.
12. 12. Harding SM, Williams PEO, Ayrton J: Pharmacology of cefuroxime as the 1-acetoxyethyl ester in volunteers. Antimicrob Agents Chemother 1984;25:78-82.
13. 13. Murray PR, Washington JA: Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 1979;50:339-344.
14. 14. Bauer AW, Kirby WMM, Sherris JC, et al: Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45: 493-496.
15. 15. Barry AL, Jones RN, Thornsberry C: Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: Reassessment of the ‘class representative’ concept, confirmation of disk interpretive criteria, and proposed quality control guidelines. J Clin Pathol 1983;80:182-189.
16. 16. Ericsson HM, Sherris JC: Antibiotic sensitivity testing: Report of an international collaborative study. Acta Pathol Microbiol Immunol Scand B 1971, suppl, p 217.
17. 17. Ginsburg CM, McCracken GH Jr, Patruska M, et al: Pharmacokinetics and bactericidal activity of cefuroxime axetil. Antimicrob Agents Chemother 1985;28:504-507.
18. 18. Sommers DK, Van Wyk M, Williams PEO, et al: Pharmacokinetics and tolerance of cefuroxime axetil in volunteers during repeated dosing. Antimicrob Agents Chemother 1984;25:344-347.
19. 19. Reichman RC, Nolte FS, Wolinsky SM, et al: Single-dose cefuroxime axetil in the treatment of uncomplicated gonorrhea: A controlled trial. Sex Transm Dis 1985;12:184-187.
20. 20. Fong IW, Linton W, Simbul M, et al: Comparative clinical efficacy of single oral doses of cefuroxime axetil and amoxicillin in uncomplicated gonococcal infections. Antimicrob Agents Chemother 1986;30:321-322.
21. 21. Wanas TM, Williams PE: Oral cefuroxime axetil compared with oral ampicillin in treating acute uncomplicated gonorrhea. Genitourin Med 1986;62:221-223.
22. 22. Schift R, Van Ulsen J, Ansink-Schipper MC, et al: Comparison of oral treatment of uncomplicated urogenital and rectal gonorrhoea with cefuroxime axetil ester or clavulanic acid potentiated amoxicillin (Augmentin). Genitourin Med 1986;62:313-317.
23. 23. Finn AL, Sherrill JM, Debussey SS: A comparative study of cefuroxime axetil and cefaclor in the treatment of otitis media with effusion, abstract 600. Program and abstracts of the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy, Minneapolis, Sept 30-Oct 2, 1985.
24. 24. Gooch WM III, Swenson E, Higbee MD, et al: Comparison of cefuroxime axetil and penicillin V as therapy for group A beta-hemolytic streptococcal pharyngitis, abstract 604. Program and abstracts of the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy, Minneapolis, Sept 30-Oct 2, 1985.
25. 25. Stokley AN, Finn AL, Werner K, et al: Comparison of cefuroxime axetil (CAE) and cefaclor (CEF) in patients with skin and skin structure infections, abstract 957. Program and abstracts of the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy, Minneapolis, Sept 30-Oct 2, 1985.
26. 26. Adams DH, Wood MJ, Farrell ID, et al: Oral cefuroxime axetil: Clinical pharmacology and comparative dose studies in urinary tract infection. J Antimicrob Chemother 1985;16:359-366.
27. 27. Cooper TJ, Ladusans E, Williams PE, et al: A comparison of oral cefuroxime axetil and oral amoxicillin in lower respiratory tract infections. J Antimicrob Chemother 1985;16:373-378.